Cite
HARVARD Citation
Bang, K. et al. (2023). Efficacy and safety of lenvatinib in patients with recurrent hepatocellular carcinoma after liver transplantation. Cancer medicine. pp. 2572-2579. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Bang, K. et al. (2023). Efficacy and safety of lenvatinib in patients with recurrent hepatocellular carcinoma after liver transplantation. Cancer medicine. pp. 2572-2579. [Online].